Dr. Yashvin Onkarappa Mangala, MD

Dr. Onkarappa Mangala practices at Rust Pmg Cardiology - HOPD in Rio Rancho, New Mexico.

Dr. Onkarappa Mangala's NPI, 1184100992, was assigned on July 15, 2018. Dr. Onkarappa Mangala holds Rhode Island license LP04462.

Dr. Onkarappa Mangala's primary practice is Rust Pmg Cardiology - HOPD, at 2400 Unser Blvd SE, Rio Rancho, NM 87124.

Dr. Onkarappa Mangala's primary practice is Rust Pmg Cardiology - HOPD in Rio Rancho, New Mexico. Dr. Onkarappa Mangala is also affiliated with Presbyterian Hospital. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Onkarappa Mangala to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Onkarappa Mangala practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Onkarappa Mangala's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Onkarappa Mangala is licensed in Rhode Island.

CMS data shows 106 Medicare services from Dr. Onkarappa Mangala across 4 procedure codes in 2024, for 58 Medicare patients. Medicare paid $9,234 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 58 Medicare patients who saw Dr. Onkarappa Mangala in 2024. The largest group is 65 to 74, with 25 patients. 67% of them have high blood pressure, and 64% have high cholesterol. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Onkarappa Mangala's median patient age at 70, with 51% women.

In 2024, Dr. Onkarappa Mangala wrote 272 Medicare Part D claims for 91 patients. 91% of them were for generic drugs. CMS names the drug for 164 of them, across 10 drugs with 11 or more claims each, at $44,882 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Onkarappa Mangala for performance year 2024, reported as part of a group. Dr. Onkarappa Mangala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Onkarappa Mangala as offering telehealth.

Dmand AI links 5 papers to Dr. Onkarappa Mangala, published from 2020 to 2023. 2020 was the busiest year, with 2. Dr. Onkarappa Mangala has published most often in Cureus. Dr. Onkarappa Mangala's most frequent co-authors are Chrystina Castellon, MD, Gerald A. Colvin, DO and Rahul Kapil, MD.

CMS Open Payments shows 140 general payments to Dr. Onkarappa Mangala from 42 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 87% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,653.